Autor según el artículo: Lord E., Stockdale A., Malek R., Rae C., Sperle I., Raben D., Freedman A., Churchill D., Lundgren J., Sullivan A., Kabel J., Block K., Delpech V., Lowbury R., Yazdanpanah Y., Hows J., Del Amo J., Rüütel K.
Departamento: Medicina i Cirurgia
Autor/es de la URV: Vidal Marsal, Francisco
Palabras clave: Indicator conditions Hiv testing Aids-defining conditions hiv testing aids-defining conditions
Resumen: Objectives European guidelines recommend HIV testing for individuals presenting with indicator conditions (ICs) including AIDS‐defining conditions (ADCs). The extent to which non‐HIV specialty guidelines recommend HIV testing in ICs and ADCs is unknown. Our aim was to pilot a methodology in the UK to review specialty guidelines and ascertain if HIV was discussed and testing recommended. Methods UK and European HIV testing guidelines were reviewed to produce a list of 25 ADCs and 49 ICs. UK guidelines for these conditions were identified from searches of the websites of specialist societies, the National Institute of Clinical Excellence (NICE) website, the NICE Clinical Knowledge Summaries (CKS) website, the Scottish Intercollegiate Guidance Network (SIGN) website and the British Medical Journal Best Practice database and from Google searches. Results We identified guidelines for 12 of 25 ADCs (48%) and 36 of 49 (73%) ICs. In total, 78 guidelines were reviewed (range 0-13 per condition). HIV testing was recommended in six of 17 ADC guidelines (35%) and 24 of 61 IC guidelines (39%). At least one guideline recommended HIV testing for six of 25 ADCs (24%) and 16 of 49 ICs (33%). There was no association between recommendation to test and publication year (P = 0.62). Conclusions The majority of guidelines for ICs do not recommend testing. Clinicians managing ICs may be unaware of recommendations produced by HIV societies or the prevalence of undiagnosed HIV infection among these patients. We are piloting methods to engage with guideline development groups to ensure that patients diagnosed with ICs/ADCs are tested for HIV. We then plan to apply our methodology in other European settings as part of the Optimising Testing and Linkage to Care for HIV across Europe (OptTEST) project.
Áreas temáticas: Psicología Pharmacology (medical) Medicina ii Medicina i Infectious diseases Health policy Ciências biológicas iii Ciências biológicas i Biotecnología
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 14642662
Direcció de correo del autor: francesc.vidal@urv.cat
Identificador del autor: 0000-0002-6692-6186
Fecha de alta del registro: 2024-09-07
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://onlinelibrary.wiley.com/doi/full/10.1111/hiv.12430
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Hiv Medicine. 18 (4): 300-304
Referencia de l'ítem segons les normes APA: Lord E., Stockdale A., Malek R., Rae C., Sperle I., Raben D., Freedman A., Churchill D., Lundgren J., Sullivan A., Kabel J., Block K., Delpech V., Low (2017). Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. Hiv Medicine, 18(4), 300-304. DOI: 10.1111/hiv.12430
DOI del artículo: 10.1111/hiv.12430
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2017
Tipo de publicación: Journal Publications